Home / Recalls / Hospira Inc. / Z-1169-2013

Z-1169-2013 Class I Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA device recall Z-1169-2013 was initiated by Hospira Inc. on Mar 18, 2013 and is designated Class I. Reason for recall: Pump shutting off during use without warning. The recall status is terminated (terminated Mar 10, 2017). Affected quantity: List Number 13000: 25,119 pumps; List Number 13100: 185 pumps; List Number 13150: 13,497 pumps.

Recall Details

Product Type: Devices
Report Date: May 8, 2013
Initiation Date: Mar 18, 2013
Termination Date: Mar 10, 2017
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: List Number 13000: 25,119 pumps; List Number 13100: 185 pumps; List Number 13150: 13,497 pumps

Product Description

The GemStar Pump is a small and lightweight, single channel infusion device designed for use in the home, in the hospital, or anywhere electronic infusion is required. The GemStar Pump can be powered by AC mains adaptor, rechargeable battery pack, docking station, or two disposable AA alkaline batteries. When powered by batteries, The GemStar Pump is ideal for ambulatory patients. The GemStar Pump is a small and lightweight, single channel infusion device designed for use in the home, in the hospital, or anywhere electronic infusion is required.

Reason for Recall

Pump shutting off during use without warning.

Distribution Pattern

Worldwide Distribution - USA (nationwide) and internationally to Australia, New Zealand, China, Hong Kong, Taiwan, Japan, Korea, Philippines, Thailand, Malaysia, Canada, Austria, Bahrain, Belgium, Croatia, Denmark, Egypt, Finland, France, Germany, Gibraltar, Greece, Hungary, Iceland, Ireland, Israel, Italy, Jordan, Kuwait, Lebanon, Libya, Luxembourg, Malta, Netherlands, Norway, Oman, Portugal, Qatar, Romania, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, UK, United Arab Emirates, Brazil, Chile and Colombia.

Code Information

List Numbers: 13000, 13100, 13150

Source

Dataset: openFDA device recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for Z-1169-2013
openFDA file date: Oct 27, 2026
Loaded by RegDataLab: Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Hospira Inc.

D-0862-2017 Class I — Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use… (Apr 21, 2017)
D-0153-2017 Class II — Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL… (Nov 1, 2016)
D-1500-2016 Class II — DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be… (Aug 15, 2016)
D-0169-2017 Class III — 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5… (Jun 29, 2016)
D-1359-2016 Class II — Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake… (Jun 23, 2016)
D-1033-2016 Class II — Vancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vial, Rx only… (May 6, 2016)
Z-1833-2016 Class II — The Plum A+ is a dual-line volumetric infusion system designed to meet the… (Mar 25, 2016)
Z-1832-2016 Class II — The Plum 360 is a large volume infuser capable of delivering fluids for a… (Mar 25, 2016)
D-1137-2016 Class I — Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20… (Mar 23, 2016)
D-0854-2016 Class III — Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20… (Mar 23, 2016)